您所在的位置: 首页 >>English >>Find a Doctor >> 正文

English

Find a Doctor

Ju YAN

字号: + - 14

晏举.jpg

Researcher, Director of Cell Genetics Laboratory, Medical Laboratory, Bachelor of Biology, Wuhan University, Ph.D. in Cell and Molecular Biology, Laval University School of Medicine, Canada, Postdoctoral Fellow, Department of Human Genetics, Commonwealth University, Virginia, USA.

He graduated from Wuhan University in 1987 with a bachelor's degree in biology. In 2000, he received his Ph.D. in Cell and Molecular Biology from the Faculty of Medicine, Laval University, Canada. In 2002, he was awarded the Certificate of Clinical Laboratory Cytogenetics by the National Certificate Administration. In 2017, it was qualified by the China Accreditation Board (CNAS) “Authorized Signatory of Cytogenetics Laboratory”.

In the mid-1970s, he established the Cell Genetics Laboratory in the Pediatrics of Wuhan Union Hospital. It is one of the first scientists in China to study and apply chromosome bands in leukemia. As early as 1981 and 1982, he published the unique chromosomal abnormalities of leukemia found in China using chromosome banding technology in the Chinese Medical Laboratory and Chinese Medical Blood Journal. In July 1987, he successively served as a teaching assistant, lecturer and director at the Department of Medical Genetics of Tongji Medical University. In 2001, he was a postdoctoral fellow in the Department of Human Genetics at the University of Commonwealth, Virginia, USA. From 2001 to July 2003, he was appointed as the head of the molecular cytogenetics laboratory by IMPATH Cancer Information Corporation (New York, USA), responsible for the establishment, guidance, management and quality control of fluorescence in situ hybridization (FISH) experiments. All experiments were successfully reported to the New York State Government for clinical diagnosis. From July 2003 to July 2013, he was appointed as an associate professor and part-time professor of the Department of Pediatrics at the SHERBROOKE University School of Medicine in Canada. He is a university-recognized researcher (PI) with qualifications for enrolling doctoral students and independent applicants. The important research results in this period are the first to propose the theory of "the change of telomere length of specific chromosomes and the pathogenesis of leukemia". Since September 2008, he has been hired as a visiting professor by Huazhong University of Science and Technology.

From September 2013 to June 2017, he was hired by Wuhan Kangshengda Medical Laboratory Co., Ltd. as the director of the Cell Genetics Platform of the Ministry of Medicine, the director for the Medical Department of Huaxi Hospital-Kangshengda Co-construction Laboratory (and concurrently) and the group's chief cytogeneticist.

As a researcher, he was awarded the Fondation des étoiles La santé des enfants par la recherche; the Canadian Research Society Inc. (a score of 209 applicants) 8th place; Quebec Life Science Research Fund - Primary Researcher Startup Fund (FRSQ-Subvention d'établissement de jeune chercheur) Quebec Life Science Research Fund Junior Scholars Scholarship (Bourse de chercheur-boursier du FRSQ, programme junior ) ; Wuhan The 7th "3551" Science and Technology Talents Special Fund. He has published more than 60 articles in well-known magazines at home and abroad。


上一篇: Qinlong ZHENG

下一篇: Hui ZHANG